|Last Price$12.53||Day Change (%)0.08%|
|Open Price$12.53||Day Change ($)0.01|
|Day Range12.53–12.53||52-Week Range12.19–12.80|
As of Fri 04/21/2017 | USD
Global $228.8 Billion Generic Drugs Market 2017-2022 - Key Players are Freseunis, Hospira , Mylan, Novartis, Sandoz & Teva Pharmaceuticals - Research and Markets
$25.8 Billion Infusion Pumps and Devices - Technologies and Global Markets - Coverage of Medical, Scientific, Technological, Social & Economic Issues - Research and Markets
Despite the high 39% premium to Hospira's stock price, we believe the acquisition price is justified based on Pfizer's ability to unlock more value with its global reach.
Welcome to Hospira's First Quarter 2014 Conference Call. All lines have been placed on listen-only mode to prevent any background noise. Following the speakers' remarks, there will be a question-and-answer period.
Four candidates stood out from their growth counterparts.